Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

I am searching for a
Reset Form
Roger B. Cohen, MD

Roger B. Cohen, MD Physician

Associate Director of Clinical Research, Abramson Cancer Center Director, Hematology/Oncology Fellowship Program Professor of Medicine at the Hospital of the University of Pennsylvania

Dr. Cohen is employed by Penn Medicine.

About Dr. Roger B. Cohen

Recognized by America's Top Doctors 2011 - 2018

Recognized by Best Doctors in America 2011 - 2018

Recognized in Philadelphia magazine's annual Top Docs issues, 2011 - 2019

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties


  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1986
  • Internal Medicine, 1984
  • Medical Oncology, 1993

Clinical Expertise:

  • Adenoid Cystic Carcinoma
  • Diaphragm Tumor
  • Ear and Temporal Bone Tumors
  • Esophageal Cancer
  • Head and Neck Tumor
  • Laryngeal Cancer
  • Lung Cancer
  • Lung Carcinoid Tumor
  • Merkel Cell Carcinoma
  • Mesothelioma
  • Mouth Cancer (Oral Cancer)
  • Nasal Cavity and Paranasal Sinus Cancer
  • Nasopharyngeal Cancer
  • Neck Cancer
  • Non-Small Cell Lung Cancer
  • Oropharyngeal Cancer
  • Salivary Gland Cancer
  • Sinus Cancer
  • Small Cell Lung Cancer
  • Thoracic Cancer
  • Throat Cancer
  • Thymoma and Thymic Carcinoma
  • Thymus Cancer
  • Tongue Cancer
  • Tonsil Cancer
  • Tracheal Cancer
View More

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Harvard Medical School
Residency: Mount Sinai Medical Center
Fellowship: Mount Sinai Medical Center
Fellowship: National Cancer Institute


American Association for Cancer Research, National American Society of Clinical Oncology, National Eastern Cooperative Oncology Group, National Heat Biologics, National Millennium Pharmaceuticals Discovery Oncology Scientific Advisory Board, National

Hospital Affiliation

Dr. Cohen is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Selected Publications:

Bauml Joshua M, Vinnakota Ravi, Anna Park Yeun-Hee, Bates Susan E, Fojo Tito, Aggarwal Charu, Di Stefano Jessica, Knepley Christina, Limaye Sewanti, Mamtani Ronac, Wisnivesky Juan, Damjanov Nevena, Langer Corey J, Cohen Roger B, Sigel Keith: Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data. Cancer 125 (3): 406-415,2019.

Ott Patrick A, Bang Yung-Jue, Piha-Paul Sarina A, Razak Albiruni R Abdul, Bennouna Jaafar, Soria Jean-Charles, Rugo Hope S, Cohen Roger B, O'Neil Bert H, Mehnert Janice M, Lopez Juanita, Doi Toshihiko, van Brummelen Emilie M J, Cristescu Razvan, Yang Ping, Emancipator Kenneth, Stein Karen, Ayers Mark, Joe Andrew K, Lunceford Jared K: T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 37 (4): JCO2018782276,2018.

Aggarwal Charu, Thompson Jeffrey C, Black Taylor A, Katz Sharyn I, Fan Ryan, Yee Stephanie S, Chien Austin L, Evans Tracey L, Bauml Joshua M, Alley Evan W, Ciunci Christine A, Berman Abigail T, Cohen Roger B, Lieberman David B, Majmundar Krishna S, Savitch Samantha L, Morrissette Jennifer J D, Hwang Wei-Ting, Elenitoba-Johnson Kojo S J, Langer Corey J, Carpenter Erica L: Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer. JAMA oncology : 2018.

Aggarwal Charu, Cohen Roger B, Morrow Matthew P, Kraynak Kimberly A, Sylvester Albert J, Knoblock Dawson M, Bauml Joshua, Weinstein Gregory S, Lin Alexander, Boyer Jean, Sakata Lindsay, Tan Sophie, Anton Aubrey, Dickerson Kelsie, Mangrolia Drishty, Vang Russell, Dallas Michael, Oyola Sandra, Duff Susan, Esser Mark T, Kumar Rakesh, Weiner David B, Csiki Ildiko, Bagarazzi Mark: Immunotherapy targeting HPV 16/18 generates potent immune responses in HPV-Associated Head and Neck Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (1): 110-124,2018.

Romero Sally A D, Brown Justin C, Bauml Joshua M, Hay Jennifer L, Li Q Susan, Cohen Roger B, Mao Jun J: Barriers to physical activity: a study of academic and community cancer survivors with pain. Journal of cancer survivorship : research and practice : 2018.

Bauml Joshua M, Vinnakota Ravi, Anna Park Yeun-Hee, Bates Susan E, Fojo Tito, Aggarwal Charu, Limaye Sewanti, Damjanov Nevena, Di Stefano Jessica, Ciunci Christine, Genden Eric M, Wisnivesky Juan P, Ferrandino Rocco, Mamtani Ronac, Langer Corey J, Cohen Roger B, Sigel Keith: Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck. Journal of the National Cancer Institute : 2018.

Smit Egbert F, Garon Edward B, Reck Martin, Cappuzzo Federico, Bidoli Paolo, Cohen Roger B, Gao Ling, O'Brien Lisa M, Lee Pablo, Zimmermann Annamaria, Ferry David R, Melemed Allen S, Pérol Maurice: Exposure-response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer. Cancer chemotherapy and pharmacology 82 (1): 77-86,2018.

Lockhart A Craig, Bauer Todd M, Aggarwal Charu, Lee Carrie B, Harvey R Donald, Cohen Roger B, Sedarati Farhad, Nip Tsz Keung, Faessel Hélène, Dash Ajeeta B, Dezube Bruce J, Faller Douglas V, Dowlati Afshin: Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors. Investigational new drugs : 2018.

Romero Sally A D, Jones Lee, Bauml Joshua M, Li Q Susan, Cohen Roger B, Mao Jun J: The association between fatigue and pain symptoms and decreased physical activity after cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 26 (10): 3423-3430,2018.

Aggarwal Charu, Haas Andrew R, Metzger Susan, Aguilar Laura K, Aguilar-Cordova Estuardo, Manzanera Andrea G, Gómez-Hernández Gregoria, Katz Sharyn I, Alley Evan W, Evans Tracey L, Bauml Joshua M, Cohen Roger B, Langer Corey J, Albelda Steven M, Sterman Daniel H: Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion. Molecular therapy : the journal of the American Society of Gene Therapy 26 (5): 1198-1205,2018.

Academic Contact Info

Division of Hematology-Oncology
Perelman Center for Advanced Medicine
10th Floor, South Pavilion
Office #10-139

Philadelphia, PA 19104
Phone: (215) 662-4469
Patient appointments: 800-789-7366 (PENN)